Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Naturbasiertes Therapieprogramm für die Parkinson-Krankheit (PARC) (PARC)

2. November 2026 aktualisiert von: Rubens da Silva, Université du Québec à Chicoutimi

Nature-based Therapy Program for Sustainable Health in Parkinson's Disease (PARC Project) - A Clinical Trial

The goal of this clinical trial is first to determine the feasibility and to learn if a nature-based program has positive effects on the physical and psychosocial health in a group of participants with Parkinson's disease. The main questions for this purpose are:

Will the program improve:

  • The physical outcomes such as mobility, strength and balance?
  • The psychosocial health outcomes?

Participants will participate in one session per week of the intervention and be assessed before and after the program. First, the adherence will be measured as the proportion of supervised outdoor sessions completed. Dropout rate will correspond to participants who will not finish the 8-week protocol, including pre- and post-intervention assessments. Satisfaction will be evaluated with a post-intervention questionnaire rating the exercise component, nature-based activities, and the PARC program on a 4-point Likert scale (0-3), capturing clarity, usefulness, difficulty, and acceptability. Adverse effects will be documented throughout the intervention. Qualitative benefits such as increased hope and improved social interaction will be collected after sessions.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The chronic and neurodegenerative disease of Parkinson's (PD) is often characterized by movement and balance disorders, which are accompanied by an increased risk of falls. Falls are one of the most common problems that can lead to subsequent injuries (e.g., femoral head fracture) and associated mortality rates. Falls are frequent, debilitating, and have deleterious effects on self-confidence and the quality of life of individuals with PD. Additionally, according to Parkinson Canada, a high proportion of individuals living with this disease suffer from depression and/or anxiety. Therefore, it is essential to implement intervention programs aimed at improving the physical and functional capacity as well as the well-being of this population to prevent falls and promote sustainable health.

In recent years, an increasing number of studies have demonstrated the benefits of contact with nature on the physical and mental health of individuals. Specific and positive effects on psychological symptoms (e.g., depression) as well as cognition (memory) in adults have also been shown according to this recent evidence. This stimulates our research team to test the effects of a physical intervention in nature on the physical and mental health of individuals suffering from PD. One of the perspectives of this new intervention in nature is also to evaluate its impact on fall risks in this population. The ultimate goal of this project is to contribute to the sustainable health of the population.

The overall objective of this project, based on a pilot study, is to assess the feasibility and the effects of an 8-week nature-based intervention program on the physical and mental health of individuals with PD. The feasibility indicators are:

Adherence - proportion of supervised outdoor sessions that will be completed by participants; Dropout Rate - proportion of participants who will not complete the full 8-week protocol, including pre- and post-intervention assessments; Satisfaction - participant satisfaction will be measured with a brief post-intervention questionnaire using a 4-point Likert scale assessing clarity, usefulness, difficulty, and acceptability of the NBI/PARC program; Adverse Effects - any adverse events will be documented throughout the intervention; and Perceived Benefits - qualitative feedback will be collected on perceived benefits such as increased hope and improved social interaction. In addition, various physical measures (mobility, strength, and balance) and mental measures (level of depression, stress) will be studied in this project to better understand the effects of this type of intervention.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

11

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Quebec
      • Saguenay, Quebec, Kanada, G7H 2B1
        • Rubens da Silva

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

45 Jahre bis 85 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • diagnosed with Parkinson's disease (while medicated: ON);
  • capable of walking independently;
  • presenting mild to moderate disability symptoms according to the Hoehn and Yahr scale (stages 1-3);
  • having a frailty score of less than 2/5 (Fried);
  • having a cognitive status ≥26 based on the Mini-Mental State Examination (MMSE) questionnaire.

Exclusion Criteria:

  • Cancer;
  • Red flags (infection, tumor, etc.);
  • Severe psychiatric disorders;
  • Palliative care;
  • Severe systemic syndromes or diseases that may prevent tests and exercises from being performed;
  • Stroke - very acute phase (1 week) and this until medial hemodynamic stability.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Nature-based intervention

Nature-based group intervention of once a week for 8 weeks

Activities in nature such as walking, exercises (strengthening, mobility, balance), pedal boat, yoga, dance, mindfulness, meditation, forest bathing or Shinrin-Yoku, interpretation of nature

Andere Namen:
  • Naturbasierte Therapie

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Depression state (PHQ-9)
Zeitfenster: change from baseline at 0 to 8 weeks

The Patient Health Questionnaire-9 (PHQ-9) is a self-administered tool used to screen, diagnose, monitor, and measure the severity of depression. It consists of nine questions based on the diagnostic criteria for major depressive disorder in the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition).Respondents rate how often they have experienced each symptom over the past two weeks on a scale ranging from 0 (not at all) to 3 (nearly every day). The scores are then added together to produce a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms

change from baseline at 0 to 8 weeks
Retention rate
Zeitfenster: 8 weeks

roportion of participants completing the full 8-week protocol including pre- and post-intervention assessments.

8 weeks
Adherence to supervised outdoor sessions
Zeitfenster: 8 weeks

Proportion of scheduled supervised outdoor sessions completed by each participant.

8 weeks
Dropout rate
Zeitfenster: 8 weeks

Proportion of participants who discontinue participation before completing the protocol.

8 weeks
Participant satisfaction
Zeitfenster: Post-intervention

Participant Satisfaction was measured using the "Participant Satisfaction Likert Scale", a 4-point scale ranging from 0 (strongly disagree) to 3 (strongly agree). Higher scores indicate greater satisfaction with the intervention, including clarity of instructions, perceived usefulness, exercise difficulty, and overall acceptability.

Post-intervention
Adverse effects
Zeitfenster: 8 weeks

Number and type of adverse events reported during the intervention.

8 weeks
Qualitative feedback on perceived benefits
Zeitfenster: through study completion, an average of 8 weeks.

Qualitative feedback collected after each session through brief open-ended questions documenting perceived benefits such as increased hope, enhanced social interaction, and other emergent themes.

through study completion, an average of 8 weeks.
Well-being state (WHO-5)
Zeitfenster: change from baseline at 0 to 8 weeks

The World Health Organization Well-Being Index (WHO-5) is a widely used self-reported questionnaire designed to measure subjective well-being. It assesses the individual's overall psychological well-being and quality of life. The WHO-5 consists of five simple questions that ask respondents to rate their well-being over the past two weeks. The questions cover aspects such as positive mood, vitality, and general interest in life.

The questionnaire is scored on a scale from 0 to 100, with higher scores indicating better well-being.

change from baseline at 0 to 8 weeks
Social Provisions (SPS-10)
Zeitfenster: change from baseline at 0 to 8 weeks

The Social Provisions Scale-10 (SPS-10) is a shorter version of the original Social Provisions Scale (SPS). It is a brief self-report questionnaire designed to measure perceived social support across five dimensions. The SPS-10 is derived from the longer SPS but consists of a subset of items that capture key aspects of social support.

Similar to the original SPS, respondents rate their agreement with each item on a Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). The SPS-10 provides a quick and efficient way to assess an individual's perceived social support network and their satisfaction with various aspects of their social relationships.

change from baseline at 0 to 8 weeks
Connection to nature (CNS)
Zeitfenster: change from baseline at 0 to 8 weeks

The Connection to Nature Scale (CNS) is a psychological assessment tool designed to measure an individual's subjective connection to nature. It evaluates the degree to which people perceive themselves as a part of the natural world and the extent to which they appreciate and value nature in their lives.

Respondents are asked to rate their agreement with each statement on a Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The scores are then totaled to provide an overall measure of an individual's connection to nature.

change from baseline at 0 to 8 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Functional mobility test (TUG)
Zeitfenster: change from baseline at 0 to 8 weeks

To assess mobility. Equipment: A stopwatch. Directions: Patients wear their regular footwear and can use a walking aid, if needed. Begin by having the patient sit back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor.

change from baseline at 0 to 8 weeks
5 times Sit-To-Stand (FTSTS)
Zeitfenster: change from baseline at 0 to 8 weeks

f the 30 second sit to stand test was not applied for some patients, we used also this test which it measures the amount of time it takes for a patient to sit and stand five times in succession with arms folded across their chest. 2 trials were applied in this test and the best time in seconds used for analysis.

change from baseline at 0 to 8 weeks
Maximal isometric hand grip strength
Zeitfenster: change from baseline at 0 to 8 weeks

Jamar dynamometer to assess maximal isometric hand grip strength and frailty criteria. 3 trials of maximal contraction up 5 seconds. The best value was retained and corrected by body mass index from Fried classification.

change from baseline at 0 to 8 weeks
Postural control
Zeitfenster: change from baseline at 0 to 8 weeks

Measures of center of pressure (COP) from plateform of force during different balance tasks

change from baseline at 0 to 8 weeks
Walking pattern
Zeitfenster: change from baseline at 0 to 8 weeks

Gait parameters from GaitRite system (14-ft walkway) measurement across two speeds: preferred and fast, with a sampling frequency of 100 Hz.

change from baseline at 0 to 8 weeks
10 m walk test
Zeitfenster: change from baseline at 0 to 8 weeks

The test was performed along a 14 m walkway, with timing initiated at the 2 m mark and stopped at the 12 m mark to ensure steady state walking. Each participant completed two trials at both comfortable (preferred) and maximal walking (fast) speeds, and the best time for each condition was retained for analysis.

change from baseline at 0 to 8 weeks

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Modified Falls Efficacy Scale (M FES)
Zeitfenster: change from baseline at 0 to 8 weeks

The confidence in performing daily activities without falling was evaluated using the French version of the Modified Falls Efficacy Scale (M FES), consisting of 14 items rated from 0 (no confidence) to 10 (complete confidence), with higher scores indicating greater falls related self efficacy.

change from baseline at 0 to 8 weeks
Frailty criteria from Fried (inclusion criterium only)
Zeitfenster: change from baseline at 0 to 8 weeks

The presence of frailty criteria according to Fried was assessed with self-report questions and two physical tests from five characteristics : 1) Low physical activity (to capture history of sedentary behavior or activity: ex. Do you get any physical exercise for the sake of exercising? How often do you leave your house?); 2) fatigue (complaint of exhaustion with normal activity such as walking outside, climbing stairs: ex. I felt that everything I did was an effort in the last week?); 3) weight loss (unintentional weight loss 10 lbs. or more in past year or more than 5% in past year); 4) weakness (grip strength evaluated with manual dynamometer; in average <30 kg for men and <18 kg for women, but data is normalized by body mass index); 5) slowness or slow walking speed (usual gait speed over 4.57 meters (15 feet); ex. >6.5 seconds, dependent of height).

change from baseline at 0 to 8 weeks
Hoehn and Yahr Scale
Zeitfenster: Only at baseline from Sample characterization when Parkinson was included

It is a five-point scale used by doctors and researchers to rate the degree of disability and severity of symptoms caused by Parkinson's disease:

Stage 1: Unilateral involvement only Stage 1.5: Unilateral and axial involvement Stage 2: Bilateral involvement without impairment of balance Stage 2.5: Mild bilateral disease with recovery on pull test Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent Stage 4: Severe disability; still able to walk or stand unassisted Stage 5: Wheelchair bound or bedridden unless aided

Only at baseline from Sample characterization when Parkinson was included
Cognitive status
Zeitfenster: Only at baseline from Sample characterization

Mini-mental state questionnaire (MMSE or Folstein), which is used for grading the cognitive state of patients in this study. It's assessing the attention and orientation, memory, registration, recall, calculation, language and ability to draw a complex polygon.

It is ranged from 0 to 30, where 30 means no impairment.

Only at baseline from Sample characterization

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Mitarbeiter

Ermittler

  • Studienstuhl: Marie-Ève Langelier, MD, Université du Québec à Chicoutimi
  • Hauptermittler: Rubens da Silva, PhD, Université du Québec à Chicoutimi
  • Studienstuhl: Émilie Fortin, PT, Université du Québec à Chicoutimi
  • Studienstuhl: Mireille Cliche, SW, Université du Québec à Chicoutimi

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

5. August 2024

Primärer Abschluss (Tatsächlich)

7. Oktober 2024

Studienabschluss (Tatsächlich)

7. Oktober 2024

Studienanmeldedaten

Zuerst eingereicht

22. Mai 2024

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

4. Juni 2024

Zuerst gepostet (Tatsächlich)

11. Juni 2024

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

2. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2024-1664

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .